IRIS Accounts Production v24.3.2.46 07511945 director 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075119452023-01-31075119452024-01-31075119452023-02-012024-01-31075119452022-01-31075119452022-02-012023-01-31075119452023-01-3107511945ns15:EnglandWales2023-02-012024-01-3107511945ns14:PoundSterling2023-02-012024-01-3107511945ns10:Director12023-02-012024-01-3107511945ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3107511945ns10:SmallEntities2023-02-012024-01-3107511945ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3107511945ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3107511945ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3107511945ns10:FullAccounts2023-02-012024-01-3107511945ns10:OrdinaryShareClass12023-02-012024-01-3107511945ns10:RegisteredOffice2023-02-012024-01-3107511945ns5:CurrentFinancialInstruments2024-01-3107511945ns5:CurrentFinancialInstruments2023-01-3107511945ns5:Non-currentFinancialInstruments2024-01-3107511945ns5:Non-currentFinancialInstruments2023-01-3107511945ns5:ShareCapital2024-01-3107511945ns5:ShareCapital2023-01-3107511945ns5:RetainedEarningsAccumulatedLosses2024-01-3107511945ns5:RetainedEarningsAccumulatedLosses2023-01-3107511945ns5:FurnitureFittings2023-02-012024-01-3107511945ns5:ComputerEquipment2023-02-012024-01-3107511945ns5:FurnitureFittings2023-01-3107511945ns5:ComputerEquipment2023-01-3107511945ns5:FurnitureFittings2024-01-3107511945ns5:ComputerEquipment2024-01-3107511945ns5:FurnitureFittings2023-01-3107511945ns5:ComputerEquipment2023-01-3107511945ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3107511945ns5:WithinOneYearns5:CurrentFinancialInstruments2023-01-3107511945ns5:AcceleratedTaxDepreciationDeferredTax2024-01-3107511945ns5:AcceleratedTaxDepreciationDeferredTax2023-01-3107511945ns5:DeferredTaxation2023-01-3107511945ns5:DeferredTaxation2023-02-012024-01-3107511945ns5:DeferredTaxation2024-01-3107511945ns10:OrdinaryShareClass12024-01-31
REGISTERED NUMBER: 07511945 (England and Wales)











Unaudited Financial Statements

for the Year Ended 31 January 2024

for

Fircastle Medical Limited

Fircastle Medical Limited (Registered number: 07511945)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Fircastle Medical Limited

Company Information
for the Year Ended 31 January 2024







DIRECTOR: E D Jones





REGISTERED OFFICE: The Point Clinic
1 De Grey Square
De Grey Road
Colchester
Essex
CO4 5YQ





REGISTERED NUMBER: 07511945 (England and Wales)





ACCOUNTANTS: Knights Lowe Ltd
Chartered Accountants
Crane Court
302 London Road
Ipswich
Suffolk
IP2 0AJ

Fircastle Medical Limited (Registered number: 07511945)

Statement of Financial Position
31 January 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 10,714 11,091

CURRENT ASSETS
Debtors 5 616,885 522,712
Cash at bank and in hand 22,783 30,233
639,668 552,945
CREDITORS
Amounts falling due within one year 6 85,836 73,012
NET CURRENT ASSETS 553,832 479,933
TOTAL ASSETS LESS CURRENT LIABILITIES 564,546 491,024

CREDITORS
Amounts falling due after more than one
year

7

(16,667

)

(26,667

)

PROVISIONS FOR LIABILITIES 8 (2,093 ) (2,107 )
NET ASSETS 545,786 462,250

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 545,686 462,150
SHAREHOLDERS' FUNDS 545,786 462,250

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Fircastle Medical Limited (Registered number: 07511945)

Statement of Financial Position - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 January 2025 and were signed by:





E D Jones - Director


Fircastle Medical Limited (Registered number: 07511945)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Fircastle Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable and is net of trade discounts. VAT is not applicable. The policies adopted for the recognition of turnover are as follows:

Rendering of services

Turnover is recognised when there is a right to consideration based on the completion of osteopathy services provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable and loans with related parties.

Debt instruments that are payable or receivable within one year, such as trade payables or receivables, are measured at the undiscounted amount of the cash or other consideration expected to be paid or received. Debt instruments that are repayable or receivable after one year are initially measured at the present value of the future cash flows and subsequently at amortised cost using the effective interest method.

Financial assets that are measured at cost and amortised cost are assessed at the end of each financial year for evidence of impairment. If objective evidence of impairment is found an impairment loss is recognised in the Income Statement.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Fircastle Medical Limited (Registered number: 07511945)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2023 - 6 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 February 2023 27,280 12,776 40,056
Additions 4,471 - 4,471
At 31 January 2024 31,751 12,776 44,527
DEPRECIATION
At 1 February 2023 17,616 11,349 28,965
Charge for year 3,534 1,314 4,848
At 31 January 2024 21,150 12,663 33,813
NET BOOK VALUE
At 31 January 2024 10,601 113 10,714
At 31 January 2023 9,664 1,427 11,091

Fircastle Medical Limited (Registered number: 07511945)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 2,106 3,161
Amounts owed by group undertakings 613,574 517,979
Other debtors 1,205 1,572
616,885 522,712

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,000 10,000
Trade creditors 1,206 2,472
Taxation and social security 62,951 50,459
Other creditors 11,679 10,081
85,836 73,012

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 16,667 26,667

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances 2,093 2,107

Deferred
tax
£   
Balance at 1 February 2023 2,107
Provided during year (14 )
Balance at 31 January 2024 2,093

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100